Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value.
Rojo Domingo M, Do DD, Conlin CC, Bagrodia A, Barrett T, Baxter MT, Cooperberg M, Feng F, Hahn ME, Harisinghani M, Hollenberg G, Javier-Desloges J, Kallis K, Kamran S, Kane CJ, Kessler D, Kuperman J, Lee KL, Levine J, Liss MA, Margolis DJA, Matthews I, Murphy PM, Nakrour N, Ohliger M, Ollison C, Osinski T, Pamatmat AJ, Pompa IR, Rakow-Penner R, Roberts JL, Shabaik AS, Song Y, Song D, Tempany CM, Trecarten S, Wehrli N, Weinberg EP, Woolen S, Xu G, Zhong AY, Dale AM, Seibert TM.
Rojo Domingo M, et al.
J Urol. 2025 Sep;214(3):259-271. doi: 10.1097/JU.0000000000004611. Epub 2025 May 16.
J Urol. 2025.
PMID: 40377262